BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7081323)

  • 21. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
    Schwingl PJ; Ory HW; Visness CM
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives and gynecologic cancer: an update for the 1990s.
    Kaunitz AM
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal myocardial infarction and the role of oral contraceptives.
    Krueger DE; Ellenberg SS; Bloom S; Calkins BM; Maliza C; Nolan DC; Phillips R; Rios JC; Rosin I; Shekelle RB; Spector KM; Stadel BV; Stolley PD; Terris M
    Am J Epidemiol; 1980 Jun; 111(6):655-74. PubMed ID: 7386441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral contraceptives and other risk factors for gallbladder disease.
    Strom BL; Tamragouri RN; Morse ML; Lazar EL; West SL; Stolley PD; Jones JK
    Clin Pharmacol Ther; 1986 Mar; 39(3):335-41. PubMed ID: 3948473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives and breast cancer in young women.
    Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
    Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult-onset amenorrhea: a study of 262 patients.
    Reindollar RH; Novak M; Tho SP; McDonough PG
    Am J Obstet Gynecol; 1986 Sep; 155(3):531-43. PubMed ID: 3529965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.
    Hergenroeder AC; Smith EO; Shypailo R; Jones LA; Klish WJ; Ellis K
    Am J Obstet Gynecol; 1997 May; 176(5):1017-25. PubMed ID: 9166162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptives and benign breast disease: a case-control study.
    Franceschi S; La Vecchia C; Parazzini F; Fasoli M; Regallo M; Decarli A; Gallus G; Tognoni G
    Am J Obstet Gynecol; 1984 Jul; 149(6):602-6. PubMed ID: 6742041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amenorrhea and the pill].
    Verdino P; Viard R; Harter M
    Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary adenomas and oral contraceptives: a multicenter case-control study.
    Fertil Steril; 1983 Jun; 39(6):753-60. PubMed ID: 6682810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary amenorrhoea and oral contraceptives.
    Ingerslev M; Jeppesen T; Ramsing EM
    Acta Obstet Gynecol Scand; 1976; 55(3):233-8. PubMed ID: 945653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours.
    Milne R; Vessey M
    Contraception; 1991 Jun; 43(6):667-93. PubMed ID: 1868737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of endometrial cancer in young women.
    Henderson BE; Casagrande JT; Pike MC; Mack T; Rosario I; Duke A
    Br J Cancer; 1983 Jun; 47(6):749-56. PubMed ID: 6860544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
    Le MG; Bachelot A; Doyen F; Kramar A
    Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
    BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal contraception: benefits versus risks.
    Goldzieher JW
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1023-8. PubMed ID: 3674179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin-secreting pituitary adenoma: occurrence following prenatal exposure to diethylstilbestrol.
    Cunningham JR; Gidwani GP; Gupta MS; Duchesneau PM; Schumacher OP
    Cleve Clin Q; 1982; 49(4):249-54. PubMed ID: 7168914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.